600276-基本财务实时评分详情
恒瑞医药600276基本财务实时评分详情
更新时间:2021-12-02 00:00:01
股票代码
600276
当期评分
股票名称
恒瑞医药
报告日期2018-12-312019-12-312020-03-312020-06-302020-09-302020-09-30
每股经营现金流(¥)0.75340.8630.3490.63630.7512
销售净利润率(%)23.316222.871523.62723.45521.855
销售毛利率(%)85.237386.56385.544386.911586.7083
净资产收益率(%)20.6121.515.0410.0315.08
营业增长率(%)25.891633.704811.27812.792214.5652
净利润增长率(%)23.329531.15519.38949.912313.6462
每股收益(%)1.11.20.290.50.8
现金流量比率(%)111.2518154.36356.3201121.584101.7138
三项费用比重(%)45.741345.654742.747743.664844.3461
每股净资产(¥)5.35245.60175.90475.00255.3227
流动比率(%)7.24629.02338.69048.56196.5238
速动比率(%)6.83298.37358.05377.86466.0807
现金比率(%)155.9856203.9786319.9569344.3376344.3376
总资产利润率(%)20.104621.34094.60449.26914.1208
主营利润比重%329.9909332.8944298.7618311.022333.8953
应收账款(万元)377,269.28490,624.54458,841.81433,811.83589,559.01
应收票据(万元)65,887.0052,855.6742,160.8111,542.3669,098.40
预付款项(万元)56,889.9459,116.2276,751.7379,185.4448,615.99
存货(万元)103,057.37160,680.59174,491.07193,659.84173,684.87
在建工程(万元)135,725.26153,282.67147,033.79137,486.17146,725.40
应付款项(万元)138,120.92128,924.68139,374.42148,229.91148,150.69
长期借款(万元)----------
未分配利润(万元)1,311,501.331,654,760.541,786,303.141,730,793.711,890,461.20
商誉(万元)----------
流动资产(万元)429,183.75524,517.07534,752.03589,954.68696,617.10
流动负债(万元)249,363.41247,263.47274,084.52277,718.27391,935.82
恒瑞医药600276评分结果
84.85分
买入/增持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006